4-6301807-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_006005.3(WFS1):​c.2012C>T​(p.Ala671Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0028 in 1,613,206 control chromosomes in the GnomAD database, including 153 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A671S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0018 ( 10 hom., cov: 34)
Exomes 𝑓: 0.0029 ( 143 hom. )

Consequence

WFS1
NM_006005.3 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.0130

Publications

9 publications found
Variant links:
Genes affected
WFS1 (HGNC:12762): (wolframin ER transmembrane glycoprotein) This gene encodes a transmembrane protein, which is located primarily in the endoplasmic reticulum and ubiquitously expressed with highest levels in brain, pancreas, heart, and insulinoma beta-cell lines. Mutations in this gene are associated with Wolfram syndrome, also called DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), an autosomal recessive disorder. The disease affects the brain and central nervous system. Mutations in this gene can also cause autosomal dominant deafness 6 (DFNA6), also known as DFNA14 or DFNA38. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
WFS1 Gene-Disease associations (from GenCC):
  • Wolfram-like syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, ClinGen, Orphanet
  • Wolfram syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • autosomal dominant nonsyndromic hearing loss 6
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cataract 41
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Wolfram syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • type 2 diabetes mellitus
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 20 uncertain in NM_006005.3
BP4
Computational evidence support a benign effect (MetaRNN=0.00240466).
BP6
Variant 4-6301807-C-T is Benign according to our data. Variant chr4-6301807-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 45445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00179 (272/152330) while in subpopulation SAS AF = 0.0481 (232/4826). AF 95% confidence interval is 0.043. There are 10 homozygotes in GnomAd4. There are 189 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AD,AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WFS1NM_006005.3 linkc.2012C>T p.Ala671Val missense_variant Exon 8 of 8 ENST00000226760.5 NP_005996.2
WFS1NM_001145853.1 linkc.2012C>T p.Ala671Val missense_variant Exon 8 of 8 NP_001139325.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WFS1ENST00000226760.5 linkc.2012C>T p.Ala671Val missense_variant Exon 8 of 8 1 NM_006005.3 ENSP00000226760.1

Frequencies

GnomAD3 genomes
AF:
0.00176
AC:
268
AN:
152212
Hom.:
9
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0489
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00608
AC:
1524
AN:
250600
AF XY:
0.00800
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000653
Gnomad FIN exome
AF:
0.000476
Gnomad NFE exome
AF:
0.0000969
Gnomad OTH exome
AF:
0.00294
GnomAD4 exome
AF:
0.00290
AC:
4242
AN:
1460876
Hom.:
143
Cov.:
98
AF XY:
0.00414
AC XY:
3008
AN XY:
726798
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33480
American (AMR)
AF:
0.0000894
AC:
4
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.000453
AC:
18
AN:
39700
South Asian (SAS)
AF:
0.0445
AC:
3836
AN:
86258
European-Finnish (FIN)
AF:
0.000362
AC:
19
AN:
52440
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000818
AC:
91
AN:
1111990
Other (OTH)
AF:
0.00407
AC:
246
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
331
661
992
1322
1653
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00179
AC:
272
AN:
152330
Hom.:
10
Cov.:
34
AF XY:
0.00254
AC XY:
189
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41586
American (AMR)
AF:
0.000327
AC:
5
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5182
South Asian (SAS)
AF:
0.0481
AC:
232
AN:
4826
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68022
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000290
Hom.:
0
Bravo
AF:
0.000438
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00703
AC:
853
Asia WGS
AF:
0.0420
AC:
144
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 02, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WFS1: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jan 26, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala671Val in Exon 8 of WFS1: This variant is not expected to have clinical si gnificance because it has been identified in 5% (832/16512) of South Asian chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs71530907). -

Jun 19, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

WFS1-Related Spectrum Disorders Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Monogenic diabetes Benign:1
Nov 10, 2017
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG criteria: PP3 (3 predictors), BP4 (7 predictors), BS2 (140 cases and 135 controls in type2diabetesgenetics.org), BS1 (6% South Asian)=Benign -

Wolfram syndrome 1 Benign:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Potent mutations in WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy.However no sufficient evidence is found to ascertain the role of this particular variant rs71530907 yet. -

Autosomal dominant nonsyndromic hearing loss 6 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
0.40
DANN
Benign
0.78
DEOGEN2
Benign
0.18
T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.72
.;T
MetaRNN
Benign
0.0024
T;T
MetaSVM
Uncertain
0.041
D
MutationAssessor
Benign
0.55
N;N
PhyloP100
-0.013
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.4
N;N
REVEL
Uncertain
0.30
Sift
Benign
0.56
T;T
Sift4G
Benign
0.43
T;T
Polyphen
0.45
B;B
Vest4
0.14
MVP
0.85
ClinPred
0.0029
T
GERP RS
-8.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.022
gMVP
0.61
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71530907; hg19: chr4-6303534; API